documents: FDA-2020-D-1137-0017

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1137-0017 FDA FDA-2020-D-1137 Investigational COVID–19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction Notice Correction 2020-10-07T04:00:00Z 2020 10 2020-10-07T04:00:00Z   2021-02-09T19:31:29Z 2020-22142 0 0 09000064848e55db

Links from other tables